Innogest Capital

Innogest Capital

Innogest Capital is a Milan based venture capital firm focused on investments in healthcare and digital technology based companies.

Innogest Capital is a Milan, Italy based venture capital firm, with offices in Milan, Geneva and San Francisco. They invest in early and later stage companies the healthcare and digital technology sectors. Innogest Capital has over €200 million in capital under management.

In healthcare, they focus on medical devices, diagnostics and digital health with a focus on therapeutic possibilities in cardiovascular, neurology and oncology. In digital, they invest with a focus on food technology, financial technology, fashion technology and lifestyle technology.

Investment

Innogest Capital have made investments in Newronika, Renovacor, armadioverde, Soul-K, MioAssicuratore, Supermercato24, Erydel, GreenBone Ortho, Anaconda BioMed, CornerJob and Medlumics.

They have exited investments in Digital Magics, Silicon Biosystems, Mobango and TheBlogTV.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Empatica

Empatica designs and develops devices for seizure monitoring and neurological research.

Beintoo is an advertising company founded by Antonio Tomarchio, Filippo Privitera and William Nespoli.

Anaconda Biomed is a Spain-based company.

3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Claudio Giuliano

CEO

Claudio Rumazza

Partner

Erminia Munao

Accounting

Giovanni Leo

Partner

Giuseppe Doagemma

Chairman of the Board

Hadi Abderrahim

Partner

Hiroaki Tanaka

Partner

Marco Millini

Portfolio Progress Manager

Sergio Maistrello

Communication and Press Office

Teresa Sanseverino

Fund Administration

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.